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ABSTRACT 
This study investigated the effects of vaccine type, sire, day, threshold rectal 
temperature status, and their potential interactions on growth, daily feed intake and 
daily feed bunk frequency in response to a standardized Bovine Viral Diarrhea Virus 
(BVDV) challenge.  Yearling, F2 and F3 Nellore-Angus steers (n = 380) from the Texas 
A&M McGregor Genomics herd were utilized over 4 years, and were stratified by sire 
over three vaccine groups of modified-live (MLV), killed (KV), and non-vaccinated 
(NON).  Vaccines were used in accordance to label directions, and MLV steers were 
separated from KV and NON steers for 7 to 10 days to prevent transmission of viral 
particles.  All steers were intranasally challenged with BVDV type 1b strain CA0401186A 
on day 0 of each year.  Clinical signs of illness and feeding behavior data were collected 
daily, while rectal temperature and weight records were collected at days 0, 3, 7, 10, 
14, 28, and 42 post-vaccination. 
The influence of sire was a significant source of variation as both a main effect 
or as an interaction term for all response variables analyzed.  Vaccine type was a 
significant source of variation as components of interaction terms; lower (P < 0.05) 
mean rectal temperature was seen in MLV as compared to KV and NON steers.  
Variation from sire and vaccine type interaction suggests the potential of matching 
genetic profiles and vaccine protocols to achieve optimum levels of production 
measures. 
ii 
Daily feed intake and daily bunk visit frequency tended to decrease through day 
7, but these traits should be interpreted separately due to the effects of sire and sire by 
vaccine type interactions.  Higher number of bunk visits did not explain levels of intake 
within some sire groups and vaccine groups.  Lung tissue disruption based on color 
scores of 3 or 4, on 5-point scale was present in more than 65% of cattle that did not 
have elevated rectal temperature above 40oC, the threshold basis for provision of 
antibiotic treatment.  Interactions involving sire, vaccine type or rectal temperature 
status with other factors in this trial illustrates complexity regarding interpretation of 
cattle health impacts on production traits. 
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 INTRODUCTION 
 
Bovine Respiratory Disease (BRD) remains one of the most common and 
expensive health related threats to the U.S. beef cattle industry.  Added costs accrue 
from the effects of reduced animal performance, prevention methods, antibiotic 
therapy, and in severe cases animal death.  In spite of prevention and treatment 
efforts, there is evidence that morbidity manifests as sub-clinical illness and can result 
in irritations of the lungs or pulmonary tissue damage in animals that have never been 
identified for illness.  Breed differences pertaining to BRD occurrences have been 
reported but the understanding of the genetic influences of BRD is limited.  Treatment 
and prevention methods against BRD have been largely disputed as well.  Vaccine 
efficacy and vaccine strategy also remains largely questioned as does antibiotic use in 
current treatment regimes.  One of the key viral agents of the BRD complex, Bovine 
Viral Diarrhea Virus (BVDV), threatens cattle production systems not only from its 
threat of morbidity and mortality from transient infection, but also the immune 
suppressive capabilities and the incidence of cattle persistently infected with the virus.   
The objectives of this dissertation are to investigate the relationships of 
vaccination strategy and health related measures with production traits of feed intake 
and growth performance of cattle with known genetic background following a Bovine 
Viral Diarrhea Virus challenge.
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 LITERATURE REVIEW 
Animal health can be summarized as the overall physical condition and well-
being of animals.  In beef cattle, morbidity (sickness) can result in economic losses due 
to reduction in performance and create additional costs associated with treatment or 
mortality (death loss).  Smith (1998) concluded that morbidity and mortality in growing 
cattle on pasture and in feedlots can be the result of numerous disorders, but most 
commonly respiratory and digestive associated diseases. 
Bovine Respiratory Disease 
Bovine Respiratory Disease (BRD) is a broad, multifaceted disease which 
includes viral and bacterial agents.  Occurrences of BRD are the result of pathogenic 
bacteria and the presence of one or more viral infections (Daniels et al., 2000).  The 
viral agents that contribute to BRD are Bovine Herpes Virus-1 (BHV-1), Parainfluenza-3 
virus (PI-3), Bovine Respiratory Syncytial Virus (BRSV) and Bovine Viral Diarrhea Virus 
(BVDV).  Suppression of immune response activity by these viruses can facilitate 
development of bacterial pneumonia caused by Mannheimia haemolytica, Pasteurella 
multocida, Histophilus somni, and Mycoplasma spp. (Fulton et al., 2000a; 2002; 2006).  
In addition to viral and bacterial exposure, reduced disease resistance typically occurs 
under instances of stress.  Stress in growing cattle systems includes transportation, co-
mingling of different groups of animals, weaning, and processing creates scenarios 
where cattle immune systems are compromised, thus providing a scenario for higher 
BRD incidence (Blecha et al., 1984).  Duff and Galyean (2007) also discussed that BRD 
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 has the most prevalent occurrence following shipping, especially from auction barns 
where cattle are co-mingled.  Furthermore, (Edwards 2010) stated that cattle are at a 
higher risk early in the feeding period when viral and bacterial exposure is compounded 
with high stress during arrival periods.  Pre-exposed cattle of various geographic 
locations, breed types, immune status, and management systems are comingled in the 
feed yard or shortly before arrival through regional auctions. 
Bovine Respiratory Disease costs  
In terms of financial strain on the U.S. cattle industry, BRD incidence is a burden 
in beef cattle operations of an enormous scale.  Griffin et al. (1997) summarized an 
estimated annual loss of $750 million due to BRD incidence.  Chirase et al. (2001) 
reported a similar range of estimated loss of $800 to $900 million annually from death 
loss occurrence, reduced feed intake and reduced weight gain, and treatment-
associated costs.  McNeill et al. (1996) summarized Texas A&M Ranch to Rail data and 
concluded that a difference of $93 added expense per animal was attributed to cattle 
treated for BRD versus cattle that were not treated. In terms of additional costs related 
to treatment alone, NAHMS (2000) reported that the average cost of treatment for one 
animal in a large feedlot setting (8,000 head or more capacity) was $16.26, and the cost 
of treatment for one animal in a small feedlot setting (1,000 to 7,999 head capacity) 
was $11.09; NAHMS (2013a) showed those figures have increased over the past 
decade.  Table 1 displays the cost comparisons of single BRD cases from 1999 NAHMS 
as compared to 2011 NAHMS reports for small and large feedlot settings. 
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  Table 1. Cost comparisons of single BRD case 1999 NAHMS vs. 2011 NAHMS 
 1,000 – 7,999 capacity 8,000 or more capacity 
1999 NAHMS $11.09 $16.26 
2011 NAHMS $23.40 $23.90 
 
 
 
Coupling the incidence of morbidity due to BRD and the negative economic 
impact is an industry wide concern.  Galyean et al. (1999) calculated that 52% of U.S. 
feedlot morbidity was a result of BRD.  Snowder et al. (2006) reported incidence of BRD 
as high as 43.8% in 18,112 cattle over a 15-yr period from herds at the US Meat Animal 
Research Center at Clay Center, NE.  Edwards et al. (1996) reported morbidity of up to 
82% as the result of BRD and summarized that morbidity and mortality from BRD was 
most common in the first 45 days after arrival at the feedlot. 
Bovine Respiratory Disease clinical diagnosis 
Traditionally, illness in cattle has been identified by changes in behavior that 
differ from what is expected in “healthy” cattle.  Trained animal handling personnel 
identify illness based on signs of depression, increased rectal temperature, lethargy, 
nasal and ocular secretions, gauntness, coughing and combinations of these ailments. 
Therapy or treatments are then applied accordingly.  Limitations of effectively 
determining clinical illness exist due to the severity of ailment.  Duff and Galyean (2007) 
summarized that observable signs of illness, as described above, and a rectal 
temperature over 40o C (104.0o F) is indicative of BRD presence.   
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 Pulmonary tissue lesions 
Given increased knowledge about BRD, a gap exists between observations of 
illness and true infection.  Wittum et al. (1996) observed 6-mo old calves (n = 469), that 
were monitored and treated for BRD from birth through harvest and concluded that 
78% of cattle treated for BRD had pulmonary lesions evident at slaughter, whereas 68% 
of untreated steers also displayed pulmonary lesions at slaughter.  Gardner et al. (1999) 
also observed the presence of lung lesions in 29% of non-treated Charolais steers (n = 
222), that had been vaccinated with a modified live vaccine prior to feedlot entry and 
health evaluation.  Similar observations were made by Schneider et al. (2009) where 
60.6% of cattle never treated for illness had lung abrasions present, and 74% of cattle 
that were treated for illness also displayed lung tissue damage.  These cattle (n = 1656), 
originated from 10 different herds from the midwest and southeast United States.  The 
above described observations reflect the nature of subjective evaluations and the 
accuracy or inaccuracy of diagnosis of clinical illness by feedlot, or cattle health 
personnel.  Table 2 summarizes additional published reports with lung lesion data. 
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 Table 2. Comparisons of published reports for lung lesion data in feedlot cattle 
 
 
 
It is important to note that previous illness status is not available prior to health 
monitoring system and treatment of the individual studies listed in Table 2.  So it 
should be acknowledged that lung lesion causing morbidity could have occurred prior 
to trial observations.  Given the high percentage of cattle that had lung lesions but 
were not treated for BRD, obvious limitations exist for diagnosis of illness based on 
visual signs of morbidity alone.  The explanation for this high amount of subclinical 
illness is largely unknown, however, Noffsinger and Locatelli (2004) indicated this 
phenomenon may be related to predator/prey behavior as cattle may view feedlot or 
animal health personnel as predators, consequently hiding or masking visual signs of 
ailments to avoid drawing attention. 
 
 
Author/Study n Treated % Treated for BRD, but no lesions 
Not treated 
for BRD, but 
lesions 
present 
Bryant et al. (1999) 439 17.0% 63.0% 42.0% 
Buhman et al. (2000) 170 35.3% NR 83.3% 
Gardner et al. (1999) 222 50.0% 37.0% 29.0% 
Schneider et al. (2009) 1665 8.17% 36.0% 60.6% 
Thompson et al. (2006) 2036 22.6% 9.9% 38.4% 
Wittum et al. (1996) 469 35.0% 22.0% 68.0% 
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 Bovine Respiratory Disease effects on feeding behavior 
Clearly, detection of subclinical illness is challenging, and therefore estimates of 
the true prevalence of BRD can be easily misjudged.  Aside from visual signs of 
morbidity, feed intake and feeding behavior have also been documented from healthy 
versus unhealthy cattle. 
  Hutcheson and Cole (1986) reported the averages of 18 experiments and overall 
94.6% of “healthy” calves were observed eating as compared to 83.4% of calves 
classified as “morbid.”  Additionally, cattle identified as “morbid” had lower feed intake 
(as a percentage of body weight) by 0.9% as compared to healthy steers at 1.55% in the 
first 7 days after arrival.  Using an electronic monitoring system, Buhman et al. (2000) 
observed lower frequency and duration of feed intake behavior in newly arrived feedlot 
cattle that were identified as sick on days 11 through 27 after arrival.  On days 28 
through 57 however, steers previously labeled as “sick” recorded higher frequency and 
duration of feeding as compared to their non-sick cohorts.  Sick steers were identified 
using a scoring system that included a rectal temperature of greater the 40.0°C, visual 
signs of changes in attitude, cough, nasal secretion, ocular secretion, and hematologic 
examinations.  Sowell et al. (1999) observed similar results in two, 32-day experiments 
where newly received cattle from various Texas sale barns were co-mingled, processed, 
and placed in one pen containing the GrowSafe® System.  Cattle classified as healthy 
based on visual assessment from feedlot personnel had more bunk visits each day, 
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 spending more time at those bunk visits as well.  In trial 1, 57 of 108 steers were 
classified as morbid, and in trial 2, 117 of 143 calves were classified as morbid. 
Bovine Respiratory Disease effects on weight gain 
 A reduction in weight gain was reported by Gardner et al. (1999) as they 
observed 1.47 kg/d for treated cattle and 1.53kg/day for untreated cattle using visual 
symptoms and rectal temperature greater than 40°C.  Roeber et al. (2001) also 
observed similar response in cattle treated more than once having 0.25 kg/d reduction 
in average daily gain (ADG) as compared to cattle not being treated based on visual 
diagnosis of morbidity.  Schneider et al. (2009) reported cattle that were treated for 
BRD, or had presence of lung lesions, had a 0.07 kg/d reduction in ADG as compared to 
non-treated cattle with no lung lesions. 
 Conflicting evidence exists in the literature for ADG response and BRD 
incidence.  Wittum et al. (1996) found no difference in ADG between treated and 
untreated cattle, but concluded that 68% of untreated steers displayed pulmonary 
lesions at slaughter.  Retrospective analyses in this experiment concluded that steers 
exhibiting lung lesions, regardless of treatment status, did have a 0.076 kg/d reduction 
in ADG as compared to cattle exhibiting no signs of lung lesions upon harvest.  
Breed differences for Bovine Respiratory Disease occurrence  
Incidence and morbidity of BRD has been recorded between breeds, although it 
has not been widely researched.  Muggli-Cockett et al. (1992) reported Pinzgauer 
offspring had a higher incidence frequency for BRD postweaning (24.6%) compared to 
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 the lowest incidence frequency (11.8%) in Angus herds from the Germ Plasm Utilization 
project where 10,142 cattle were evaluated from 1983 to 1988.  Snowder et al. (2006) 
also evaluated MARC herd BRD data from 1987 to 2001, and observed that incidence 
frequency for BRD was highest for Pinzgauer, Braunvieh, Simmental, and Limousin at 
35%, 34%, 33%, and 32%, respectively.  Angus was the lowest at 10.2%, and the overall 
mean was 12.8% in the 12 breeds represented.  Snowder et al. (2005) also reported 
MARC III composite (¼ Angus, ¼ Hereford, ¼ Pinzgauer, ¼ Red Poll) as not only having a 
lower incidence frequency of BRD at 9.7%, but also had one of the highest mortality 
rates at 17.2%.  They concluded that some breeds or breed combinations are inherently 
more sensitive to BRD impacts and show more visual signs of BRD morbidity.  
Mitigation of Bovine Respiratory Disease   
Vaccinations have been shown to be an important solution for reducing the 
negative effects of many diseases.  In terms of minimizing BRD occurrences, 
preventative methods have been heavily researched.  Snowder et al. (2006) discussed 
practices that prevent pathogen introduction, limit exposure, and reduce transmission 
are all important steps upon entry into the feedlot.  It is a common practice that BRD 
preventative protocols are applied based on the perceived risk assessment of a pen or 
lot of cattle received in commercial feedlot operations.  Vaccines and other 
antimicrobials reduce incidence and severity of a disease outbreak, but are limited in 
terms of their ability to prevent and eradicate BRD entirely.  A broad selection of 
commercial vaccines and antibiotic pharmaceuticals are available, however, none 
9 
 
 include protection against all BRD pathogens (Perino, 1997).  However, feedlot 
managers and animal health experts do perceive the use of pharmaceuticals as 
beneficial, as reflected by the National Animal Health Monitoring System (NAHMS).  
NAHMS (2013b; 2013c) reported that 96% of cattle in feedlots over 1,000 head capacity 
utilize a respiratory vaccine upon arrival and 26% of those same cattle are administered 
an antibiotic upon arrival as well.  In feedyards of fewer than 1,000 head capacity 92.6% 
of the cattle received BRD vaccine but 31% were administered an antibiotic upon 
arrival. 
 Reducing the amount of stress incurred during the receiving period is important, 
especially for those cattle who are higher risk and more immune-compromised than 
others.  Duff and Galyean, (2007) discussed that the benefits of metaphylaxis programs 
and prevention methods are attention worthy for susceptible cattle that are higher risk.  
In a review of preconditioning methods, Cole (1985) concluded that preconditioned 
animals had increased ADG on-farm and within the first 45 days of the feedlot period, 
and that morbidity and mortality rates were reduced by 23% and 0.7%, respectively, as 
compared to non-preconditioned contemporaries. More recent research has also 
supported these general findings as seen in Table 3. 
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 Table 3. Comparisons of performance in preconditioned and non-preconditioned calves in the 
scientific literature 
(As adopted from Mathis, 2008) 
 
 
 
Health impacts on growth 
The disciplines of growth, immunology, and beef cattle management have 
traditionally been studied and discussed with little reference to the complex nature of 
their over-lapping biological functions and associated variables.  Gifford et al. (2012) 
summarized the impacts of immune response on physiological features that can lead to 
changes in growth.  Following exposure of cattle to, and subsequent inflammation 
from, infection by viral and bacterial agents, the acute phase response occurs within 48 
hours post infection.  Stimulation of pro-inflammatory cytokines leads to fever, 
anorexia, muscle catabolism, and alters liver protein synthesis.  Gifford et al. (2012) 
summarized that acute phase cytokines are highly expressed in damaged tissues 
Author/Study Preconditioned Non-Preconditioned 
Cravey (1996) 
Morbidity (cost per head) 
Mortality 
ADG 
 
$13.74 
0.5% 
1.31, kg/day 
 
$30.66 
2.6% 
1.17, kg/day 
 
Roeber et al. (2001) 
Morbidity 
Mortality 
ADG 
 
 
35% 
1.1% 
1.61, kg/day 
 
 
77% 
11.4% 
1.69, kg/day 
Lalman et al. (2005) 
Mobidity 
Mortality 
ADG 
 
 
7.0% 
0.1% 
-- 
 
 
29.0% 
3.0% 
-- 
11 
 
 following immune response, and negatively affect the precursors to metabolism in 
human, mouse and swine models.  In cattle, it is also hypothesized that a repartitioning 
of nutrients is directed toward immune response, and ultimately survival, instead of 
increasing skeletal muscle tissue growth. 
Bovine Viral Diarrhea Virus  
 Since the focus of this research is the impact of Bovine Viral Diarrhea Virus 
(BVDV) on immune response and performance traits, this pathogen is now discussed in 
more detail.  Aside from the losses of cattle at all phases of beef production, the other 
major threat of BVDV comes from persistently infected (PI) cattle.  Calves persistently 
infected with BVDV result from vertical transmission of BVDV from the infected dam’s 
bloodstream to her fetus during pregnancy (Larson et al., 2002). 
 Bovine Viral Diarrhea hinders beef cattle production on a substantial economic 
scale as the estimated cost of a single occurrence of PI in a beef cow herd has been 
estimated to range from $14.85 to $24.84 per cow annually (Larson et al., 2002).  
Hessman et al. (2009) observed growing cattle (n = 15,348), and economic analyses 
revealed performance losses were $88.26/animal due to exposure to PI calves; 
prevalence of PI cattle in this report was 0.04%.  A similar observation was made by 
Loneragen et al. (2005), who reported the prevalence of PI cattle in commercial 
feedlots was 0.3%, and the presence of a single PI animal in a pen resulted in 43% 
increase of treatment for BRD. 
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 Bovine Viral Diarrhea Virus persistent infection  
 It is important to note that the cause of PI calves is in-utero exposure between 
days 45 to 175 of pregnancy (Groom, 2004).  Prior to development of the fetal immune 
system, PI calves fail to create an immune response to the BVD virus because they fail 
to distinguish the virus from itself, and these cattle subsequently serve as reservoirs of 
infection for other cattle (Chase et al., 2008).  Because of a failure to respond to the 
infection, PI cattle continuously shed BVD virus through horizontal transmission from 
one animal to others through mucosal secretions (Larson et al., 2002).  Wittem et al. 
(2001) reported estimates of 18.5% of PI calves decease at or before weaning.  
Estimates by Loneragan et al. (2005) indicate that 33% of PI cattle will live through the 
finishing process of beef production systems and be harvested with their non-PI 
contemporaries.  Larson et al. (2004) estimated similar figures of 17% to 40% of PI 
cattle can reach puberty and breeding ages.  Ultimately, these figures represent an 
elevated exposure of non-infected cattle to BVDV in all production phases. 
Bovine Viral Diarrhea Virus classifications 
 Bovine Viral Diarrhea virus can be classified into 2 genotypes (BVD type 1 and 
BVD type 2).  Beyond these distinctions, each genotype occupies several subtypes such 
as BVD1a, BVD1b, BVD1c, etc; BVD1b being the most prevailing subtype in U.S. 
feedlots, whereas BVD1d is the most common in subtype in the Australian cattle 
industries (Fulton et al., 2003b; 2009).  Beyond these genotype separations, different 
BVD biotypes exist.  The biotype is defined as cytopathic (CP) or non-cytopathic (NCP) 
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 (Ahn et al., 2005).  These biotypes are classified based on the presence or absence of 
visible cytopathic, degenerative or degrading, effects in infected cell cultures.  
Observation by Ahn et al. (2005) recorded differences in occurrence of biotypes for 
BVDV such that 30% of samples were defined as CP and 70% were classified NCP.  
Fulton et al. (2000b) reported similar figures in vaccinated and non- vaccinated steers 
with 20.8% of collected samples being CP and 79.2% of samples NCP. 
Bovine Viral Diarrhea Virus clinical symptoms 
 Clinical symptoms of BVDV as reviewed by Peterhans et al. (2003) and Fulton et 
al. (2003a) include those similar to other respiratory infections.  Further, the virus can 
affect the digestive tract, fetal development, and the immune system in addition to 
causing mucosal disease.  Bovine Viral Diarrhea virus has a dual nature for infection; 
BVDV itself serves as an infectious agent itself, but it also serves as an immune-
suppressor of health defenses (Baker, 1995).  With defense mechanisms suppressed, 
secondary bacterial colonization occurs which commonly leads to subsidiary infections 
(Edwards et al., 1986). 
Bovine Viral Diarrhea Virus laboratory diagnosis 
 In terms of handling the occurrences of BVD, an important aspect is accurate 
screening and diagnosis of PI calves.  Sandvik (2005) described in detail numerous 
methods of laboratory testing for BVD virus itself, by through virus isolations, or by 
immune function response to BVD, through virus neutralizing antibodies.  Cornish et al. 
(2005) summarized important characteristics of laboratory testing for detecting PI 
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 calves to have large capacity, be economical, accurate, and timely in order to be 
suitable for practical application. 
Immune system considerations 
 Immunity is the ability to resist disease or infection from foreign substances that 
threaten wellbeing, and the nature of the immune system is very complex. Two 
segments of immune function exist, referred to as innate and adaptive.  The innate 
system includes non-specific response mechanisms, and the adaptive immune system is 
antigen specific and involves immunological memory (Abbas and Lichtman, 2007).  The 
principal components of innate immunity are (1) physical and chemical barriers, such as 
epithelia and antimicrobial substances produced at epithelial surfaces; (2) phagocytic 
cells (neutrophils, macrophages) and natural killer (NK) cells; (3) blood proteins, 
including members of the complement system and other mediators of inflammation; 
and (4) cytokine proteins that regulate and coordinate many of the activities of the cells 
of innate immunity.  
 The mechanisms of innate immunity are specific for structures that are common 
to groups of related microbes and may not distinguish fine differences between foreign 
substances.  Innate immunity provides the initial lines of defense against foreign 
microbes (Abbas and Lichtman, 2007).  Conversely, the adaptive immune system has 
the capacity to distinguish among different, even closely related microbes and 
molecules, and for this reason is also called specific immunity (Abbas and Lichtman, 
2007).  
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  Two types of adaptive immune responses, humoral and cell-mediated, can also 
be considered.  Cell-mediated immunity is derived from different components of the 
immune system and functions to eliminate different types of microbes.  Humoral 
immunity is mediated by antibodies in the blood and mucosal secretions and produced 
by B lymphocytes (B-cells).  Cell-mediated immunity, also called cellular immunity, is 
mediated by T lymphocytes (T-cells).  Intracellular microbes, such as viruses and some 
bacteria, survive and proliferate inside phagocytes and other host cells, where they are 
inaccessible to circulating antibodies.  Defense against such infections is a function of 
cell-mediated immunity, promoting the destruction of microbes residing in phagocytes 
or the killing of infected cells to eliminate reservoirs of infection (Abbas and Lichtman, 
2007).  
 Protective immunity against a microbe may be induced by the host’s response 
to the microbe or by the transfer of antibodies or lymphocytes specific for the microbe.  
The form of immunity that is induced by exposure to a foreign antigen is called active 
immunity because the immunized individual plays an active role in responding to the 
antigen (Abbas and Lichtman, 2007).  Immunity can also be conferred on an individual 
by transferring serum or lymphocytes from a specifically immunized individual.  The 
recipient of such a transfer becomes immune to the particular antigen without ever 
having been exposed to or having responded to that antigen.  Therefore, this form of 
immunity is called passive immunity (Abbas and Lichtman, 2007), and is the primary 
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 mechanism by which cows provide immunity to their calves through colostrum, as very 
little to no passive transfer occurs across the placenta in cattle.   
Vaccine products generally contain modified-live (MLV) or killed viruses and 
bacteria toxins known to cause diseases.  These products are administered to induce 
the body’s immune system into creating antibodies and develop immunological 
memory (Faries, 1999). Adjuvants are also included in available vaccines to slow the 
release of the antigen into the system to extend the immune response; adjuvants also 
elicit an innate response.   
Historically, most killed vaccine adjuvants have been comprised of aluminum 
hydroxide or oil and water combinations (Roth and Hednerson, 2001). Vaccines can 
contain an assortment of biological agents such as inactive toxins (known as toxoids), 
killed bacteria (known as bacterins) and combinations of adjuvants which elevate the 
level of effectiveness of the antigens (Faries, 1999).  Faries (1999) also summarized that 
vaccines are identified as either infectious or noninfectious.  Infectious vaccines contain 
an organism that is modified or altered to reduce its virulence so that it will not cause 
disease, but will still be infectious enough to provide immunity.  Modified live vaccines 
are infectious vaccines that achieve a desired level of infection.  Immunity of the animal 
prevents the establishment of disease and provides immunity.  Noninfectious vaccines 
are unable to infect or replicate infectious agents.  Generally, noninfectious vaccines 
are weaker in their ability to illicit an immune response, so a second dose, or booster, is 
required 2-4 weeks later.  The initial dose of vaccine is a priming-sensitizing dose that 
17 
 
 provides little to no protection and the booster provides protection for 6 to 12 months 
(Faries, 1999). 
Protective immunity against viruses from vaccination 
There appear to be some discrepancies among reports pertaining to the 
effectiveness and duration of protection that vaccines provide for BVD.  Cortese et al. 
(1998) concluded that vaccination with a MLV BVD Type 1 triggered antibodies to 
numerous strains of both BVD type 1 and BVD type 2 virus strains that were detectable 
18 months post vaccination.  Fulton et al. (1995) indicated a decline in BVD antibody 
titers by day 140 following vaccination.  Step et al. (2009) showed that single and 
multiple vaccinations of BVDV prevented disease incidence prior to PI exposure.  
Furthermore, in an evaluation of the effect of PI-BVDV exposure to non-exposed cattle, 
Booker et al. (2008) concluded that pens containing animals PI with BVDV type 1 had 
more BRD treatments and mortalities, but calves PI with BVDV type 2 had no effect on 
the health of non-exposed calves.  These conflicting results in the literature may be 
because of the type of virus present in the PI animals. There are thousands of strains of 
BVDV with widely varying levels of morbidity incidence (Ridpath et al., 2007). 
 Some vaccines that target specific antigens, such as toxoid vaccines, are meant 
to completely prevent disease from infection, whereas vaccines formulated for more 
complex agents of disease that tend to have more numerous antigenic strains are less 
likely to produce a complete prevention level of protection (Faries, 1999).  Callan and 
Garry (2002) summarized respiratory vaccines as disease modifiers rather than absolute 
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 preventative agents.  Additional benefits of vaccination exist which not only protects 
vaccinated individuals, but also reduces the ability to shed infections to pen mates or 
newly arrived comingled calves (Frank et al., 2003).  
 Viruses use two different strategies to infect hosts.  Peterhans (2003) reviewed 
that a virus may either cause a persistent infection in individual animals to infect new 
hosts, or, viruses can also use the ‘hit-and-run” strategy which is a short duration, 
transient infection followed by a rapid transfer to a different host and continued 
replication in other animals. 
 Virulence of BVDV has been characterized as having a broad range of effects 
based upon the amount of infection or severity of infection induced (Ridpath et al., 
2007).  Liebler-Tenorio et al. (2003) observed differences in clinical observations and 
rectal temperature changes in colostrum deprived, non-vaccinated steers less than 4 
months of age when challenged with 2 different BVDV type 2 strains.  Observations 
were made following an intranasal challenge of a naturally occurring low virulent strain, 
or a highly virulent strain isolated from a severe field outbreak.  Calves receiving the 
low virulent strain expressed a mildly elevated body temperature at day 7 following 
challenge with no changes in feed intake or observable behavior differences.  
Conversely, calves inoculated with the highly virulent strain exhibited elevated body 
temperature (> 40oC) shortly following challenge which persisted for several days.  
Calves in the high virulence group also became lethargic and apathetic in behavior.  
Similar findings were made by Kelling et al. (2002) where 5 different isolates of BVDV 
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 type II (2 highly virulent strains and 2 lowly virulent strains) were experimentally 
induced into 6 to 9 month old crossbred calves.  Kelling et al. (2002) observed that 
calves inoculated with high-virulence strains developed more signs of respiratory tract 
disease, displayed elevated rectal temperature 6 days following inoculation, and 
exhibited more lethargic demeanor as compared to calves challenged with low-virulent 
strains.  
 The variation in virulence presents challenges from a research standpoint.  
Efficacy of vaccine and vaccine use protocol studies in the field have been limited by 
the lack of repeatability and under-developed accepted criteria for appropriate 
research models.  Traditionally, results from studies using BVDV type 2 have been 
readily available; however results from BVDV type 1 challenges are less common.  One 
such BVDV1 strain that has been used in vaccines as well as a popular challenge strain is 
BVDV NY-1.  Isolated from a field case in New York, calves infected with BVDV NY-1 
were reported to respond with symptoms of pyrexia, reduction in white blood cells, 
diarrhea, reduced appetite, depression, and reddening of the gums (Baker et al., 1954).  
Ridpath et al. (2007) summarized two problems in using BVDV NY-1 when conducting 
viral challenges: (1) that clinical presentation of infection was reported as mild in 
comparison to BVDV strains R5013, R2360, and CA0401186A, and (2) the conflicting 
results in vaccine efficacy in studies using BVDV NY-1 in the treatment vaccine as well 
as the challenge virus simultaneously. 
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  One of the aforementioned BVDV strains used by Ridpath et al. (2007) that 
compared BVDV NY-1 to other field strains was used in this research project.  Bovine 
Viral Diarrhea Virus CA0401186A was discovered from a PI calf in California that was 
one of 24 calves with brain and skeletal deformities born to heifers in a single herd.  
Tissues containing CA0401186a were submitted to the USDA-ARS National Animal 
Disease Center in Ames, IA from the Tulare Laboratory of the California Animal Health 
and Food Safety Laboratory.  It was characterized as a noncytopathic biotype and found 
to be of the BVDV1b subgenotype (Ridpath et al., 2007).  
Wilson (1989) defined the efficacy of a vaccine as its ability to reduce the overall 
level of respiratory disease.  With this broad definition, a limited amount of literature 
exists pertaining to positive results for the efficacy of vaccination strategies in field 
trials.  Reasons for this limitation were summarized by Wilson (1989) in that the 
methods of identifying respiratory disease are often based on clinical observation only.  
Variables including severity of illness and length of illness are un-detected.  Finally, 
differences of repeatability issues which are unavailable in field studies as compared to 
laboratory evaluations (Wilson, 1989). 
  Considering the complex characteristics of BVDV, there is also complexity in 
BVDV vaccination strategies.  Fulton et al. (2002) observed that BVDV was an important 
contributing factor to BRD in 2 studies, with BVDV subtype 1b being the most 
predominant. Fulton et al. (2002) and Fulton et al. (2005) also briefly reviewed popular 
BRD vaccines containing BVDV, and summarized that only a small number of 
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 commercially available vaccines actually contained BVDV 1b antigenic material.  A 
problem with this strategy is that even though cattle are vaccinated with BVDV 1a or 2, 
they may still be susceptible to the most common BVDV subtype, 1b.  Fulton et al. 
(2005) concluded that vaccination with a MLV vaccine containing BVDV subtypes 1a 
and 2 did not prevent infection in vaccinated calves when exposed to PI calves with 
BVDV1b.  Fulton et al. (2003b) also reported that vaccines containing BVDV1a induce 
lower antibodies to BVDV1b than to BVDV1a in 3 separate USDA licensed vaccines. 
Summary of literature review  
 Bovine Respiratory Disease Complex remains widespread in beef cattle 
production systems.  Morbidity and mortality resulting from exposure to viral and 
bacterial infections that work in concert to activate immune responses.  Changes in 
feed intake and feeding behavior in feedlot cattle have been observed due to BRD 
infections.  Subclinical infection of BRD is a major hindrance of illness diagnosis for 
feedlot personnel as evidence of infection has been observed in pulmonary tissues, yet 
no visual signs that would warrant treatment were recorded.  Breed types and 
combinations of breeds have also been linked to a lower incidence of BRD as well.  One 
major component of BRD is Bovine Viral Diarrhea Virus.  One of the reasons BVDV 
draws much attention is due to unidentified PI calves that are a major source of 
spreading infection. Even in events of immunization, exposure to varying subtypes of 
BVDV can still result in infection leaving questionable results of vaccine efficacy.  Thus, 
research is needed that addresses the genetic influences related to health, immune 
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 responses and animal performance in cattle exposed to BVDV.  The long-term goal of 
this research is to investigate the genomic aspects of health related characterizations 
and as a preliminary component of the long-term goal, the objective for this 
dissertation is to investigate phenotypes associated with traditional production 
measures of feed intake, feeding frequency, growth performance, and morbidity 
aspects of Bos indicus crossbred steers of known genetic background following BRD 
vaccination and BVDV challenge.  To satisfy the overall goal, specific approaches 
evaluated: (1) the effects of (a) vaccine type, (b) sire groups and (c) elevated rectal 
temperature status (above 40oC for 14 days post challenge) on daily feed intake, bunk 
visit frequency, and average daily weight gain, and (2) the relationships of clinical 
morbidity signs and lung color scores at slaughter with daily feed intake, bunk visit 
frequency, and average daily gain as well as their distributions across (a) vaccine type, 
(b) sire groups and (c) rectal temperature status. Interactions involving vaccine type, 
sire group and rectal temperature status were of particular interest to be investigated.  
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 MATERIALS AND METHODS 
Animal procedures 
Half-blood (F2 and F3) Angus-Nelore steers from the Texas A&M University 
McGregor Genomics herd were utilized.  This herd represents a unique population of 
Bos taurus-Bos indicus crossbred cattle that are used to identify regions of the genome 
that are related to production traits of economic relevance.  The steers for this project 
were spring-born and not vaccinated against BRD pathogens as calves.  Steers were 
confirmed to be free of BVDV-PI prior to vaccination, and absence of PI was confirmed 
through evaluation of ear notch samples by antigen capture ELISA at the Texas 
Veterinary Medical Diagnostic Laboratory (TVMDL, Amarillo, TX).  All animal procedures 
were reviewed and approved by the Texas A&M University Institutional Animal Care 
and Use Committee (AUP# 2010-080 and 2013-0069) as well as the Texas A&M 
University Institutional Biosafety Committee.  
Steers were stratified by sire and genomics cow family across 3 vaccine 
treatment groups of killed vaccine (KV), modified-live (MLV), and non-vaccinated 
(NON). Table 4 shows the number of observations across vaccine groups and years of 
study.  
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   Table 4. Number of cattle in each vaccine type group per year 
Vaccine type 2010 (n = 78) 2011 (n = 104) 2012 (n = 106) 2013 (n = 95) 
Killed vaccine (KV) n = 28 n = 34 n = 35 n = 31 
Modified-live 
vaccine (MLV) n = 25 n = 35 n = 35 n = 33 
Non-vaccinated 
(NON) n = 25 n = 35 n = 36 n = 31 
 
 
 
Steers in the KV group received initial Vira-shield® (Novartis Animal Health US, 
Inc.) vaccine on day -56 or -49 and a booster dose on day -35, -28, or -25, depending on 
year, but with a target of 21 days between priming and booster vaccinations.  Steers in 
the MLV group were vaccinated with Arsenal 4.1® (Novartis Animal Health US, Inc.) on 
day -35, -28, or -25, depending on year, prior to the challenge.  The steers of the NON 
group remained as non-vaccinated.  Steers receiving the MLV vaccine were kept 
separate from KV and NON steers for 7 to 10 days depending upon the year.  The dates 
for vaccinations and data collections across years are summarized in Table 5. 
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 Table 5. Dates for procedures and associated day of trial across years  
 
 
On day 0, steers were challenged with a type 1b non-cytopathic BVDV strain 
(CA0401186a) obtained from the USDA-ARS National Animal Disease Center (NADC) 
(Ridpath et al., 2007).  This strain was isolated from a PI calf and submitted to the NADC 
from the California Animal Health and Food Safety Laboratory in Tulare.  Each steer 
received 5 mL of inoculum (1 × 105 TCID/mL).  A 2.5 mL dose was placed in each nasal 
passage; the animal’s nose was then elevated until it was visually observed that the 
steer had swallowed to confirm challenge virus solution was ingested.  This particular 
strain of BVDV was chosen for this study because it had previously been reported to 
 2010 2011 2012 2013 
Procedure Date Day Date Day Date Day Date Day 
KV I1 3/16 -56 3/22 -49 3/27 -49 4/16 -49 
KV II/MLV1 4/6 -35 4/15 -25 4/17 -28 5/14 -28 
Challenge 5/11 0 5/10 0 5/15 0 6/4 0 
Collect 
Data 5/12 1 -- -- -- -- -- -- 
Collect 
Data 5/14 3 5/13 3 5/18 3 6/7 3 
Collect 
Data 5/18 7 5/17 7 5/22 7 6/11 7 
Collect 
Data 5/21 10 5/20 10 5/25 10 6/14 10 
Collect 
Data 5/25 14 5/24 14 5/29 14 6/18 14 
Collect 
Data 6/8 28 6/7 28 6/12 28 7/2 28 
Collect 
Data 6/22 42 6/21 42 6/26 42 7/16 42 
1KV = killed vaccine, MLV = modified live vaccine. After 2010 it was decided not to collect 
weight or rectal temps on animals the day following challenge. 
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 cause recognized immunological and clinical signs of morbidity, but without risk of 
extreme illness or death (Ridpath et al., 2007).  
Cattle were fed a high-forage growing diet that consisted of approximately 
31.5% corn, 36.5% chopped alfalfa hay, 24.5% dry distillers grains, 2.5% commercial 
premix, and 5% molasses.  Cattle were housed and fed at the Texas A&M University 
Beef Systems Research Unit in College Station, Texas where 4 pens are equipped with a 
GrowSafe® feed intake monitoring system.  Cattle were housed so that the treatment 
groups were stratified across the 4 pens with approximately 20 to 26 steers per pen 
depending on the year.  Cattle were acclimated to the diet for 6 to 10 weeks prior to 
the challenge day in each year; however, individual intake was not accessed until after 
isolation of steers following MLV administration at which time they were placed into 
the pens they remained in until 42 days post-challenge. 
Following the 42-day post-challenge evaluation period, cattle were transported 
to a commercial feedlot and fed for approximately 150 to 180 days, then harvested at a 
commercial processing plant.  At harvest, lungs and livers of animals were evaluated for 
presence of lesions and lung color score by the same evaluator in all years.  Table 6 
explains the lung color score system description. 
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 Table 6. Lung coloration and adhesion scores 
Score Description 
1 Pink healthy lung 
2 Less than 25% discoloration 
3 More than 25% but less than 50% discoloration 
4 More than 50% but less than 75% discoloration 
5 More than 75% discoloration 
 
 
 
Sample and data collection 
Body weights were measured and rectal temperatures were evaluated via 
digital rectal thermometer on days 0, 3, 7, 10, 14, 28, and 42 following viral challenge.  
Average daily gain (ADG) was calculated from days 0 through 42 as well as three 
periods: period 1 (days 0 to 14), period 2 (days 14 to 28), and period 3 (days 28 to 42). 
 Clinical observations were conducted twice daily for 14 days following challenge 
to assess apparent health symptoms with a score of 0 (no symptoms), or 1 to 5 (least 
severe to most severe) for commonly associated symptoms of BRD/BVD (cough, ocular 
secretion, nasal secretion, depression, diarrhea, and gauntness/shrink).  From days 15 
to 42 observations were conducted once daily.  Animals exhibiting rectal temperatures 
over 40oC were administered a commercially available antimicrobial approved for cattle 
and dosed per label directions. 
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 Statistical analyses 
Mixed model procedures of SAS (SAS Inst. Inc., Cary, NC), were used for analyses 
of daily feed intake (DFI) and daily feeding frequency with a model that includes fixed 
effects of vaccine type, year, day(nested within year), sire, pen(nested within year), 
high rectal temperature status days 3 to 14 (yes or no), two-factor interactions of sire × 
vaccine type, and three-factor interaction of vaccine type × day × high rectal 
temperature status days 3 to 14 (yes or no).  Rectal temperature measurements were 
analyzed with a model that included day nested within year, pen nested within year, 
year, vaccine type, sire, and two-way interactions of day × vaccine type, and day × sire.  
Analyses of weight measurements included a model with day nested within year, pen 
nested within year, year, vaccine type, sire, and day × sire interaction.  These models 
were analyzed as repeated measures with a first order autoregressive covariance 
structure. 
Average daily gain calculated for the three 14-d periods as well as the 42-day 
period was analyzed with a model containing fixed effects of pen nested within year, 
vaccine type, sire, high rectal temperature status days 3 to 14 (yes or no), day 0 weight 
as a covariate, and two-way interactions or vaccine type × high rectal temperature 
status days 3 to 14 (yes or no), sire × high rectal temperature status days 3 to 14 (yes or 
no). 
Twenty-three steers representing 12 different sires were removed from 
analyses due to limited sire group size, which prevented appropriate stratification 
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 assignment across the three vaccine types.  Least squares means were compared for 
effects that produced a significant F-test (P ≤ 0.05) with two-tailed t-tests.   
Frequency distributions of threshold rectal temperature status, visual morbidity 
sign status and lung color scores across other study factors such as vaccine type, pen 
and year were also evaluated, and Chi-square tests were examined.   
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 RESULTS AND DISCUSSION 
 A general summary of the traits analyzed through repeated measures is 
presented in Table 7.  There was considerable individual variation for all traits.  
 
Table 7. Summary statistics for variables investigated 
Variable Mean SD CV Minimum Maximum 
Weight, kg 344.1 51.6 15.0 188.7 526.1 
Rectal temperature, oC 39.8 0.52 1.3 37.8 42.3 
Daily feed bunk visit frequency, 
visits/animal/day 70 27 38.6 1 207 
Daily feed intake, kg 10.7 2.7 25.2 0.0 21.0 
ADG days 0 to 14, kg 0.66 0.7 106.1 -1.88 3.05 
ADG days 14 to 28, kg 1.57 0.6 38.2 -1.62 3.24 
ADG days 28 to 42, kg 1.23 0.49 39.8 -0.65 3.05 
ADG days 0 to 42, kg 1.16 0.34 29.3 -0.43 1.90 
 
 
 
Significance of the fixed effects for weight and rectal temperature analyses are 
shown in Table 8.  Day within year, year, and sire were important sources of variation 
for both of these traits. Differences were also observed for vaccine type and the day × 
vaccine type interaction for rectal temperature; the day × vaccine type interaction 
approached significance for weight.    
 
 
31 
 
 Table 8. Significance levels (P-values) for effects in the weight and rectal temperature 
models 
Effect Weight Rectal temperature 
Day(Year) < 0.001 < 0.001 
Pen(Year) 0.285 0.002 
Year < 0.001 < 0.001 
Vaccine type 0.239 0.040 
Sire < 0.001 < 0.001 
Day × Vaccine type 0.091 < 0.001 
Day × Sire -- 0.148 
 
 
 
 Table 9 shows the levels of significance for the effects included in models for 
daily feed intake and daily feed bunk visits.  Day within year, pen within year, year, sire, 
the two-way sire by vaccine type interaction, and the three-way day by vaccine type by 
rectal temperature threshold status interaction influenced (P < 0.001) both of these 
traits.  
 
Table 9. Significance levels (P-values) for effects in the daily feed intake and daily bunk visit 
frequency models 
Effect Daily feed intake Daily bunk visit frequency 
Day(Year) < 0.001 < 0.001 
Pen(Year) < 0.001 < 0.001 
Year < 0.001 < 0.001 
Vaccine type .388 .646 
Sire < 0.001 < 0.001 
Sire × Vaccine type 0.001 < 0.001 
Day × Vaccine type × High rectal 
temperature status over 40oC < 0.001 < 0.001 
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  Significance levels for effects included in the ADG models are provided in Table 
10 and are presented for the total 42-day period post-challenge as well as for 14-day 
intervals.  Pen within year, year, and the regression on day-0 weight were typically 
significant effects with the exceptions being no year effect for ADG during the last 14 
days, and no significant effect of day-0 weight during the first 14 days post challenge.  
Sire was only significant for ADG during the second 14-day period; rectal temperature 
status was important for the first and third 14-day periods, but not during the second 
period or overall 42-day period.  The same models were used for all ADG periods. A 
vaccine type × rectal temperature status interaction was seen for ADG only in the 
second 14-day period, and there was a tendency for a sire × rectal temperature status 
interaction (P = 0.09) for ADG during the third period. 
 
 
 
Table 10.  Significance levels (P-values) of effects for the average daily gain models 
 ADG 
Effect Days 0 to 42 Days 0 to 14 Days 14 to 28 Days 28 to 42 
Pen(Year) .002 .003 < 0.001 0.004 
Year < 0.001 < 0.001 < 0.001 .161 
Day 0 weight < 0.001 .415 < 0.001 0.004 
Vaccine type .102 .080 0.773 0.165 
Sire .139 .483 0.055 0.133 
High rectal temperature 
status over 40oC .386 .022 0.331 0.023 
Vaccine type ×  High rectal 
temperature status over 40oC   .161 .955 < 0.001 0.352 
Sire ×  High rectal 
temperature status over 40oC .253 .657 0.230 0.087 
33 
 
 Weight analyses 
 
 Initially, it was not the intent to include year as a fixed effect in any analyses.  
Following preliminary evaluation it was concluded that including nested effects of 
day(year), pen(year) and year itself was the most appropriate method.  This method 
allowed for evaluation of the year-to-year variation, some of which is due to imbalance 
of sires across years.  Figure 1 displays the weights for the effect of day within year.  
Day 0 for years 2010 to 2013 was May 11, May 10, May 15, and June 4, respectively. 
Day 0 was delayed in 2013 to prevent potential issues with other cattle being treated 
for BRD in the same facilities in May; as a result cattle in 2013 were approximately two 
weeks older on day 0 than in previous years.  Steers in the 2012 trial were managed 
with a growing diet following weaning as compared to the steers in 2010 and 2011 
trials which were managed in a grazing with supplementation program.  These 
management differences, post weaning, helps explain the differences for weight at day 
0 of the 2012 steers as compared to 2010 and 2011 steers. 
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Figure 1. Least squares means for weight on evaluation days within year 
 
 
 
Sire group was a source of variation for overall weight with means provided in 
Figure 2.  Sires 297J and 482T were significantly higher for weight over 158U, 229T, 
497S, 673S, 7152, 7238, 7530, 8048, 8154, 8213, and 8428.  Sires 673S and 497S were 
the lowest ranking for weight.  The sire 673S was different from 12 others, but not 
different from 158U, 422T, 497S, 673S, 7152, 7238, 7530, and 8428.  Sire group 230T, 
422T, 461T, 494S, 539S, and 8154 were intermediate and only different from a few 
other sire groups. It was of interest to evaluate differences in weights among sire 
groups and compare the results to those of other traits that might be weight-
influenced. 
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Figure 2. Least squares means of weight by sire groups. 
 
 
 
Although not significant at the P ≤ 0.05 level, the interaction of vaccine type × 
day on weight approached significance (P = 0.09), and the least squares means for 
these combinations are displayed in Figure 3.  Overall 3 years, the MLV and NON 
vaccinated steers were very similar for weight, but KV steers tended to be lower at 
each observation point, and the explanation for this is unclear.  
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Figure 3. Least squares means of weight for vaccine type by day following challenge.   
KV = Killed, MLV = modified live, NON = non-vaccinated. 
 
 
 
Rectal temperature analyses 
 
A similar pattern for rectal temperatures was observed for 2010 and 2011 
across the seven collection times as they decreased from day 3 through 10 then 
became gradually higher through days 14 through 42 (Figure 4).  The least amount of 
change over the collection days was observed in the 2013 trial as no differences across 
days were significant.  The 2012 rectal temperature observations increased from day 0 
through 7, dropped significantly lower at day 10, and then increased at day 14 through 
42. 
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Figure 4. Least squares means of rectal temperature for day within year 
 
 
 
 When considering rectal temperature differences due to vaccine type, the KV 
vaccine group and NON vaccine group were higher (P ≤ 0.05) than the MLV vaccine 
group across all years (Figure 5.).  No differences were observed between the KV and 
NON vaccine groups across years.   
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Figure 5. Least squares means of rectal temperature by vaccine type.   
KV = Killed, MLV = modified live, NON = non-vaccinated. 
 
 
 
 Due to the MLV vaccinated steers having lower rectal temperature across all 
years, it was not surprising that a smaller proportion of MLV steers had rectal 
temperatures that reached above the 40.0oC threshold established for therapeutic 
treatment; 47.5% of the MLV steers exhibited high rectal temperature status as 
compared to 67.2% of the KV and NON steers.  Table 11 shows the distributions of the 
steers from known sires across vaccine types.  
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Rectal temperature status distribution for all steers in the project is displayed in 
Table 12.  Chi-square tests were used to analyze the distributions of rectal temperature 
status across other categorical study factors.  The single significant Chi-square result 
was related to vaccine type where 47.2% of the MLV steers were above the rectal 
temperature threshold, but the KV and NON steers had 66.1% and 67.5%, respectively, 
above the threshold.  Because the rectal temperature threshold of 40.0oC was the 
factor that dictated administration of BRD antibiotic treatment in this trial, this rectal 
temperature status was also evaluated as to its impact on other traits. 
 
Table 11. Distribution of high rectal temperature status over 40oC across vaccine type 
 Rectal temperature threshold status  
Vaccine 
type NO YES Total 
Killed 
(KV) 
39 80 119 
32.8% of KV row 67.2%  of KV row 
 27.7% of NO column 36.7% of YES column 
     
Modified 
live (MLV) 
62 56 118 
52.5% of MLV row 47.5%  of MLV row 
 44.0%  of NO column 25.7%  of YES column 
     
Non-
vaccinated 
(NON) 
40 82 122 
32.8% of NON row 67.2%  of NON row 
 28.4%  of NO column 37.6%  of YES column 
 
Total1 141 218 359 
1Relative to number of steers with sire known.  Distributions different (P = 0.001) across 
vaccine types based on Chi-square test. 
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 Table 12. Distributions of animals for threshold rectal temperature category in the 
14-day period following challenge across other study factors1 
 Year of trial 
 2010 2011 2012 2013 
Below 43 (55.1%) 29 (27.9%) 41 (39.1%) 38 (40.9%) 
Above 35 (44.9%) 75 (72.1%) 64 (60.9%) 55 (59.1%) 
Total 78 104 105 93 
  
 Vaccine type 
 KV MLV NON 
Below 43 (33.9%) 67 (52.8%) 41 (32.5%) 
Above 84 (66.1%) 60 (47.2%) 85 (67.5%) 
Total 127 127 126 
 Feedlot pen 
 1 2 3 4 
Below 34 (35.8%) 34 (35.4%) 37 (39.0%) 46 (48.9%) 
Above 61 (64.2%) 62 (64.6%) 58 (61.0%) 48 (51.1%) 
Total 95 96 95 94 
   
 Evidence of visual morbidity signs 
 No Yes 
Below 132 (40.4%) 19 (35.9%) 
Above 195 (59.6%) 34 (64.2%) 
Total 327 53 
1Relative to all cattle in trial (n = 380). 
 
 
 
 Significant differences for rectal temperature were observed due to sire (Figure 
6).  Sire groups 032T, 297J, 230T, 8428, and 7152 were not different from each other 
but exhibited lower (P ≤ 0.05) rectal temperatures than 8 of the 20 sire groups 
represented.  Conversely, calves in sire groups 7238, 422T, 8213, 158U, 539S, 8048, 
were higher than sire groups 032T, 297J, 230T, 8428, and 7152, but not different from 
the remaining 9 sire groups.  Sires 7238 and 8213 were higher (P ≤ 0.05) than 10 of the 
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 20 sire groups; sires 422T, 158U, 539S, 497S, 8048, 494S, 482T, 673S, 128S, 7530, 229T, 
8154, 461T did not differ from each other. When looking at the rankings of sire groups 
for rectal temperature and weight, there was no similar pattern. 
 
 
Figure 6. Least squares means of rectal temperature by sire groups 
 
 
 
Least squares means of rectal temperature for the vaccine type × day 
interaction are provided in Figure 7.  The non-vaccinated steers exhibited the highest 
amount of fluctuation across observation days.  At day 3 the non-vaccinated steers 
recorded the highest rectal temperatures (with a least squares means estimate over 
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 40.0oC) which was higher (P ≤ 0.05) than all other observations except for KV steers on 
days 3 and 7.  Day 10 for the NON vaccine group was significantly lower than the other 
days in this group while days 0, 7, 28, and 42 were not different.  Within the MLV 
group, days 0 and 28 ranked the highest, which were not different from day 42; these 
days were different (P ≤ 0.05) from days 3 and 10, and, days 3, 7, and 10 were not 
different from each other.  Considering the KV steers only, the day 10 rectal 
temperature was lowest across all days, and day 3 was highest and significantly 
different (P ≤ 0.05) from days 10, 14, and 28, but not different than day 0, 7, and 42.  It 
is not certain if rectal temperature is solely a response to the BVDV challenge, but the 
KV and NON steers had increased rectal temperature on days 3 and 7 following 
challenge whereas MLV steers had lower rectal temperature on these days.   
Different strains of BVDV impact their hosts in a variety of ways.  Kelling et al. 
(2002) observed a high response of visual signs of respiratory tract disease and 
elevated rectal temperature following experimentally induced challenge of 2 highly 
virulent strains as compared to an equal number of lowly virulent strains.  Also, the 
challenge virus in this project had been previously shown to elevate inoculated cattle’s 
rectal temperatures and project visual signs of morbid behavior without mortality in 
young Holstein calves (Ridpath et al., 2007). 
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Figure 7. Least squares means of rectal temperature by vaccine type and day. 
KV = Killed, MLV = modified live, NON = non-vaccinated. 
 
 
 
Daily feed intake 
Daily feed intake over all days nested within all years is presented in Figure 8.  
While all 4 years have a similar decreasing pattern through day 7, it appears the 2010, 
2011, 2012 daily feed intakes tend to increase through day 23 while 2013 intakes 
remain lower overall even though the 2013 steers were heavier for weight. 
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Figure 8. Least squares means of daily feed intake for days within years 
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 Sire was a source of variation for daily feed intake, and these means are given in 
Figure 9.  Steers from sires 494S and 482T had the highest overall least squares means 
estimates for daily feed intake, and these sires also ranked high for steer weight.  While 
494S and 482T were not significantly different from each other, 494S was different 
from the remaining sire groups and 482T was only similar to 539S but significantly 
higher than the remaining sires as well.  Sire groups 230T, 673S, and 8428 were on the 
lower end of rankings for daily feed intake and were not different from each other; 
these sires had steers ranked high, low and intermediate, respectively, for progeny 
weight (shown previously in Figure 2).   Steers from sires 673S and 8428 were 
significantly lower than steers from 14 of the 20 sire groups and 230T being different 
from 13 of the 20 sire groups.   
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Figure 9. Least squares means of daily feed intake by sire groups 
 
 
The least squares means for the sire by vaccine type interaction are presented 
in Figure 10.  Sires 494S and 539S ranked among the highest of all sire groups and 
vaccine type by sire combinations for daily feed intake.  The NON steers from sire 
groups 673S and 7238 ranked among the lowest and were not different from each 
other.  Steers sired by 7238 were significantly different from all sire × vaccine type 
combinations except 158U-KV, 461T-NON, and 497S-NON whereas 673S was also 
different (P ≤ 0.05) from the same sire × vaccine type combinations as 7238-sired 
calves, with the addition of the MLV steers from within the 673S sire group.
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Figure 10. Least squares means of daily feed intake for vaccine type and sire combinations 
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  Variation in the KV vaccine group across sires was not as exaggerated as the 
NON vaccine group but several differences were still observed.  Steers sired by 482T, 
494S, 7238, and 422T ranked among the highest for daily feed intake overall of the KV 
vaccine group and were not different from each other.  Steers sired by 482T being the 
highest least squares means estimate and significantly different from the remaining KV 
vaccinated steers in other sire groups except the previously mentioned high ranking 
groups within the KV vaccine type (P ≤ 0.05).  Steers sired by 230T, 7152, 8048, and 
8428 were lower ranking for daily feed intake within the KV cattle across sires, were not 
different from each other and were significantly different from 8 other sire groups, 
032T, 128S, 297J, 422T, 482T, 494S, 7238, and 7530 (P ≤ 0.05).   
 The least amount of variability across sire groups among the vaccine types was 
from the MLV group.  Steers sire by 461T and 032T were the highest ranking for least 
squares means for daily feed intake.  While progeny by 461T and 032T were not 
different from each other, sire group 032T was different from 14 of 20 sire groups and 
not different than 461T, 482T, 494S, 539S, 7152 sired steers, whereas 461T steers were 
only different from 11 sire groups and not different than 032T, 128S, 422T, 482T, 494S, 
539S, 7152, and 8213.  The low ranking sire group was 8428 which was different from 
each other sire group except 158U, 497S, and 7238.  As the number of progeny varied 
across sire groups depending upon their use in breeding, Table 13 provides steer 
numbers for sires across vaccine group and year of study, and the number of progeny 
per sire should be considered with these results. 
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 Table 13. Distribution of sires across vaccine groups and years 
  Vaccine group Year 
Sire Total KV MLV NON 2010 2011 2012 2013 
 032T 36 13 12 11 0 14 11 11 
 128S 29 10 10 9 7 0 14 8 
 158U 7 2 2 3 0 0 0 7 
 229T 21 6 7 8 0 0 14 7 
 230T 20 6 7 7 0 20 0 0 
 297J 17 7 4 6 10 0 7 0 
 422T 4 2 1 1 0 4 0 0 
 461T 5 2 1 2 0 2 3 0 
 482T 23 8 7 8 0 8 0 15 
 494S 7 2 3 2 0 0 0 7 
 497S 3 1 1 1 0 0 0 3 
 539S 10 3 4 3 0 0 0 10 
673S 9 4 3 2 0 0 0 9 
7152 8 2 3 3 3 3 2 0 
7238 7 2 3 2 2 5 0 0 
7530 15 5 5 5 3 6 6 0 
8048 36 13 11 12 18 9 9 0 
8154 21 7 6 8 8 5 8 0 
8213 28 10 8 10 5 7 16 0 
8428 31 9 12 10 6 15 10 0 
Totals1 337 114 110 113 62 98 100 77 
1Relative to steers with known sire and for sires represented across all vaccine groups. 
 
 Differences between the vaccine types within a sire group were varied for daily 
feed intake.  In 7 of 20 sire groups there were no differences due to vaccine type.  In 
sire groups 032T, 230T, 461T, 8048, and 8213 the MLV steers had significantly higher 
feed intake than their NON and KV contemporaries.  Two sire groups (482T and 7238) 
had KV steers with significantly higher intakes, and, two sires (297J and 494S) had NON 
steers that were the highest for daily feed intake (P ≤ 0.05).  The NON steers were the 
lowest for feed intake by a significant margin in 4 sire groups (461T, 482T, 673S, and 
50 
 
 7238).  Only 1 sire group had a KV or MLV vaccine type be the lowest (P ≤ 0.05) for daily 
feed intake.  In terms of responding to this viral pathogen, the effect of sire × vaccine 
type was a large contributor to the amount of variation observed for daily feed intake.  
As defined by the nature of an interaction, the impact of daily feed intake, when 
comparing vaccine types, depends greatly on the sire group in which those vaccines are 
used.  Overall, it appears that daily feed intake of non-vaccinated steers tended to be 
more varied as compared to KV and MLV vaccinated cattle, and may indicate increased 
consistency following pathogen exposure in vaccinated animals.  When considering 
individual sire groups, there was no consistent pattern for daily feed intake between 
the vaccine types.  This implies that the influence of sire groups plays an apparent role 
in daily feed intake with respect to vaccine strategy.  While it does not seem practical to 
adjust vaccine type for each individual from different sires, these results suggest there 
is potential to match sire groups with vaccine strategies to maintain suitable daily feed 
intake levels.  
 The daily feed intake was also affected by the 3-way interaction of day × vaccine 
type × high rectal temperature status with these least squares means shown in Figure 
11.  At day 3 steers classified as NON-YES and KV-YES were lowest for daily feed intake 
while not being different from each other they were both significantly different from 
KV-NO, MLV-NO, MLV-YES, NON-NO (P ≤ 0.05).  At day 4 both MLV groups were higher 
than the KV-NO steers, additionally the MLV-YES steers were different than NON-YES 
and KV-YES (P ≤ 0.05).  At day 5 all KV and MLV steers were significantly different.
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 Figure 11. Least squares means of daily feed intake for vaccine type by threshold rectal temperature status. NO = rectal 
temperature ≤ 40oC; YES = rectal temperature > 40oC for first 14 days following challenge 
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 At day 7, five vaccine type × high temperature combinations were not different 
but all others were significantly separated.  KV-NO was similar to MLV-YES and NON-
NO, NON-NO was similar to MLV-YES and MLV-NO, and NON-YES was not different 
from KV-YES (P ≤ 0.05).  Steers labeled as NON-YES were lowest at day 9 and 10 and 
only different the MLV-YES and MLV-NO respectively.  No differences observed from 
day 11 through day 13 but at day 14 MLV-NO was different from all steers classified as 
“YES” regardless of vaccine type but not different from other steers classified as “NO” 
for rectal temperature status (P ≤ 0.05). 
 The overall pattern of daily feed intake tends to decrease sharply from day 0 
through day 7, have sharp decreases and increase through day 15 then regain a stable 
pattern through days 21 and 22.  Beyond this, there appears to be a fluctuating nature 
from 1 day to the next although not as exaggerated as days 7 through 15.  Considering 
the rectal temperature analyses, it seems sensible that increases in rectal temperature 
status negatively effects daily feed intake, particularly in those cattle of the NON and 
KV vaccine groups that received antibiotic treatment due to elevated rectal 
temperature threshold above 40oC.   
Daily feed bunk visit frequency 
 Daily bunk visit frequency was measured to better explain changes in intake and 
reflect the suppression of appetite or feeding behavior for this trial.  Daily bunk visit 
frequency for all days within all years is presented in Figure 12.   In all years the same 
patterns were observed throughout the 42-day observation period.
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Figure 12. Least squares means of daily bunk visit frequency for days within years
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  Variation for daily bunk visit frequency was observed for the effect of sire, and 
the least squares means are found in Figure 13.  Progeny from 497S had 9.3 more bunk 
visits per day than the second highest ranking sire groups which were 461T, 482T, and 
8048.  While 497S was significantly higher in bunk visits as compared to all other sire 
groups, 461T, 482T, and 8048 were only different from 11 other sire groups.  Sires 
461T, 482T, and 8048 were similar to one another, but different (P ≤ 0.05) from 032T, 
128S, 229T, 297J, 494S, 497S, 7152, 7238, 8154, 8213, 8428.  There were wide 
differences in rankings of sires between bunk visits and feed intake.  Although 497S was 
the highest for bunk visits, this sire ranked among the lowest for daily feed intake.  Sire 
494S ranked the highest for feed intake but was among the lowest for bunk visits.   
There was no consistent pattern between daily bunk visit and daily feed intake for 
these sire groups. 
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Figure 13. Least squares means of daily bunk visit frequency by sire group 
 
 
Figure 14 displays the least squares means of daily bunk visit frequency for 
vaccine type by sire group combinations.  When considering the sire × vaccine type 
interaction, eight sires (229T, 297J, 422T, 673S, 7152, 7530, 8048, and 8154) had no 
differences for vaccine types among their progeny.  Overall, it was observed that 539S-
sired steers from the KV vaccine group recorded the lowest bunk visits as compared to 
his NON and MLV steers, which were not different.  Among steers sired by 497S, the 
MLV group recorded the lowest bunk visits, and the KV and NON steers were not 
different.  The NON steers sired by 7238 were the lowest in his group with MLV steers 
intermediate and KV highest with all three being different (P ≤ 0.05).  In 6 of the sire 
groups at least one of the vaccinated groups was higher for bunk visit frequency than 
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 the non-vaccinated steers.  When considering attempts to identify patterns, or 
tendencies with regard sire and vaccine type interaction, there appears to be no 
constant pattern in terms of bunk visit frequency when considering vaccine type by sire 
interaction.  The lack of identifiable pattern is indicative of substantial genetic 
differences in an animal’s response to viral pathogen exposure with respect to 
vaccination protocols.  As mentioned in the discussion of daily feed intake, under 
current production systems, it is typically considered impractical to adjust vaccine 
strategies for each sire’s offspring, however, attempts of combining parentage 
information with preferred vaccine response, has potential of adding to the animals 
overall well-being by reducing appetite suppression following viral infection.  
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Figure 14. Least squares means of daily bunk visit frequency for vaccine type and sire group combinations. 
KV = Killed, MLV = modified live, NON = non-vaccinated 
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 The interaction of vaccine type × day × high rectal temperature was a significant 
source of variation for daily bunk visit frequency as it was for daily feed intake.  The 
least squares means for daily bunk visits regarding these combinations are shown in 
Figure 15.  In general the pattern of bunk visit frequency is similar to daily feed intake 
through day 10.  Specific differences were observed on days 3 through day 8 where 
NON-YES steers were constantly lower than both MLV groups, and KV-YES steers on 
days 4 and 8.  At days 4 through 8 the MLV steers had more bunk visits regardless of 
rectal temperature status than the NON-YES steers, additionally all MLV-YES steers 
were consistently higher than all KV steers at days 4 to 6.  From days 9 to 13 no 
differences were observed between any vaccine type  × rectal temp status combination 
but at day 14 through 17 the NON-YES frequented the feed bunk the least amount and 
the NON-NO frequented the feed bunk the most, with these classifications being 
different (P ≤ 0.05) from each other.  Buhman et al. (2000) observed some similar 
patterns in that newly arrived feedlot cattle that were classified as morbid had lower 
frequency and duration days 11 through 27.  Additionally Sowell et al. (1999) observed 
healthy cattle from visual assessments had more bunk visits each day, and had longer 
duration time at those bunk visits. 
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Figure 15. Least squares means of daily bunk visit frequency for vaccine type and rectal temperature status combinations.   
KV = Killed, MLV = modified live, NON = non-vaccinated, NO = rectal temperature ≤ 40oC; YES = rectal temperature > 40oC 
during 14 days post challenge. 
40
50
60
70
80
90
100
-7 -6 -5 -4 -3 -2 -1 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41
KV-NO KV-YES MLV-NO MLV-YES NON-NO NON-YES
Da
ily
 b
un
k 
vi
sit
s 
Day 
60 
 
 Average daily gain 
Steers exceeding the rectal temperature threshold of 40oC on d 1 though 14 
exhibited a 0.24 kg/d reduction (P = 0.02) in ADG the first 14-d period following viral 
challenge, then gained 0.18 kg/d more (P = 0.02) during the final 14-d period as 
compared to steers that did not exceed the 40oC threshold (Figure 16).  Although there 
was no significant difference for steers above or below the 40oC threshold in the 
second 14-d period, both groups exhibited an increase in ADG during this period 
compared to the first 14-d period and last 14-d period.  These results from d 0 to 14 are 
similar to Roeber et al. (2001) who observed a 0.25 kg/d reduction in ADG in newly 
received preconditioned cattle identified as morbid and Schneider et al. (2009) who 
reported 0.07 kg/d ADG reduction in cattle throughout the feeding phase for cattle 
receiving BRD treatment.  Results from days 14 to 28 in this trial also agree with data 
presented by Wittum et al. (1996) who observed no differences in ADG for treated 
cattle as compared to non-treated cattle.  The data from the first 14-d period also tends 
to agree with Gardner et al. (1999) in that a 0.06 kg/d reduction in ADG was observed 
for cattle with a rectal temperature great than 40oC and having visual BRD symptoms.  
Results from these data suggests that cattle expressing high rectal temperatures 
experience reduced growth performance while cattle not expressing high temperatures 
are affected less severely 0 to 14 days following viral exposure.  All cattle compensated 
ADG days 14 to 28, and steers with rectal temperatures above 40oC in the first- 14 days 
had higher ADG 28 to 42 days following viral challenge with this BVDV strain. 
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Figure 16. Average daily gain for steers that did not (NO) versus did (YES) exceed rectal 
temperature threshold of 40.0oC in days 0 to 14 (left), days 14 to 28 (center), and days 28 to 42 
(right). 
 
 
 
With the strain of BVDV evaluated in this study, overall ADG was not different 
between steers that had elevated rectal temperature even though differences within 
periods existed, and the rectal temperature status interacted with vaccine type (Figure 
17).  Considering the vaccine type × high temperature status combination, the non-
vaccinated steers exhibited the highest and lowest values for ADG for days 14 to 28.  
The non-vaccinated steers that did not have a high rectal temperature (NON-NO) were 
significantly higher for ADG as compared to KV-NO, MLV-NO, and NON-YES steers.  
Conversely, non-vaccinated steers that exceeded rectal temperature threshold (NON-
YES), were significantly lower for ADG as compared to NON-NO, MLV-YES, and KV-YES 
steers.  Steers in the KV vaccine group were not different from steers in the MLV group.  
It seems that NON steers classified as morbid by elevated rectal temperature were at 
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 not exhibit high rectal temperatures have increased ADG days 14 through 28 following 
challenge, it may not compensate for the higher proportion of NON vaccinated steers 
that have reduced ADG. 
 
 
Figure 17. Least squares means for ADG from days 14 to 28 across vaccine type and 
rectal temperature status. KV = Killed, MLV = modified live, NON = non-vaccinated, NO 
= rectal temperature ≤ 40o C; YES = rectal temperature > 40o C. 
 
 
The least squares means presented in Figure 18 represent the variation for sire 
group as a source of variation for ADG during the second 14 day period, (days 14 to 28). 
Steers sired by 497S were the highest followed by 7530 and 8154 and these sire groups 
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 to sire and is therefore important to consider when investigating the impacts of health 
associated measures on growth and production traits.   
 
Figure 18. Least squares means for ADG from days 14 to 28 by sire groups 
 
 
 
Morbidity and lung scores 
Visual clinical symptoms were recorded twice daily on days 0 to 14, and the 
distribution of those clinical scores are displayed in Table 14.  In general, very few visual 
symptoms of morbidity were observed in any year, and animals that were documented 
with any signs were almost exclusively scored a 1.  No steers received other than a 0 for 
diarrhea, and, signs of depression, coughing and gauntness were the main morbidity 
conditions noticed.  Chi-square tests were conducted to test the relationship of the 
distributions but overall no significant differences were detected for visual clinical signs 
across other study factors. 
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Table 14. Distributions of clinical sign category during the 14-day period following 
challenge across other study factors 
 Year of trial 
Category1 2010 2011 2012 2013 
No 64 (82.1%) 91 (87.5%) 87 (82.9%) 85 (91.4%) 
Yes 14 (17.9%) 13 (12.5%) 18 (17.1%) 8 (8.6%) 
Total 78 104 105 93 
  
 Vaccine type 
 Killed Modified live Non-vaccinated 
No 112 (88.2%) 113 (89.0%) 102 (80.9%) 
Yes 15 (11.8%) 14 (11.0%) 24 (19.1%) 
Total 127 127 126 
  
 Feedlot pen 
 1 2 3 4 
No 81 (85.3%) 87 (90.6%) 82 (86.3%) 77 (81.9%) 
Yes 14 (14.7%) 9 (9.4%) 13 (13.7%) 17 (18.1%) 
Total 95 96 95 94 
1No = no sign of morbidity, Yes = any sign of morbidity.  Animals were evaluated 
twice per day by the same evaluator across all years. Only minor signs (1 or 2 on a 1-
to-5 scale) of depression, coughing or gauntness were documented. 
 
 
The lung score data are summarized in Table 15.  From the three years 2010 to 
2012, 60.8% of cattle exhibited high rectal temperature status and received therapeutic 
antibiotic treatment.  Of the cattle that showed rectal temperature over 40.0 C, 22.4% 
had no lung tissue discoloration (score of 1), 55.8% displayed the lowest level of 
discoloration (score of 2), and 21.8% had lung scores of 3 or greater, indicating 
evidence that lung tissue disruption was visually evident on more than 25% but less 
than 75% of the lung. 
65 
 
 The 22.4% of the steers that were treated for elevated rectal temperature but 
had no evidence of lung discoloration is similar to results of Wittum et al. (1996) who 
observed 22.0%.  Bryant et al. (1999), Gardner et al. (1999), and Schneider et al. (2009) 
observed higher percentages of treated cattle with no lung color disruption at 63.0%, 
37.0%, and 36.0%, respectively.  The potentially more concerning perspective from a 
production management, animal well-being and clear understanding of BRD is analyses 
of cattle that did not exhibit a high rectal temperature but still displayed evidence of 
lung discoloration.   
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  Table 15. Distribution of lung color scores across other study factors 
 
Year of trial 
Lung score 2010 2011 2012 
1 20 (25.6%) 32 (31.1%) 24 (22.9%) 
2 41 (52.6%) 55 (53.4%) 55 (52.4%) 
3 16 (20.5%) 16 (15.5%) 23 (21.9%) 
4 1 (1.3%) 0 3 (2.8%) 
Total 78 103 105 
 
Vaccine type 
 
Killed Modified-live Non-vaccinated 
1 23 (24%) 25 (26.6%) 28 (29.2%) 
2 49 (51%) 49 (52.1%) 53 (55.2%) 
3 22 (22.9%) 19 (20.2%) 14 (14.6%) 
4 2 (2.1%) 1 (1.1%) 1 (1%) 
Total 96 94 96 
 
Feedlot pen 
 
1 2 3 4 
1 21 (29.6%) 16 (22.5%) 17 (23.9%) 22 (30.1%) 
2 35 (49.3%) 41 (57.8%) 38 (52.5%) 37 (50.7%) 
3 14 (19.7%) 12 (16.9%) 16 (22.6%) 13 (17.8%) 
4 1 (1.4%) 2 (2.8%) 0 1 (1.4%) 
Total 71 71 71 73 
 
Evidence of visual signs 
 
No Yes 
1 66 (27.4%) 10 (22.2%) 
2 122 (50.6%) 29 (64.5%) 
3 49 (20.3%) 6 (13.3%) 
4 4 (1.7%) 0 
Total 241 45 
 
Rectal temperature threshold 
 
Below Above 
1 37 (33%) 39 (22.4%) 
2 54 (48.2%) 97 (55.8%) 
3 21 (18.8%) 34 (19.5%) 
4 0 4 (2.3%) 
Total 112 174 
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 Only 33% of the cattle below 40oC threshold had lung color score of 1 which 
indicated ideal lung color, with no visual discoloration or evidence of infection; 48.2% 
of the cattle with below 40oC had a lung score of 2, and 18.8% had a score of 3 
(discoloration of greater than 25% but less than 50% of the visual lung tissue).  As 
compared to prior studies, these numbers are within the similar ranges of observations 
made Bryant et al. (1999), Buhman et al. (2000), Gardner et al. (1999), Schneider et al. 
(2009), Thompson et al. (2006), and Wittum et al. (1996) which reported 42.0%, 83.3%, 
29.0%, 60.6%, 38.4%, and 68.0%, respectively for cattle with lung lesions present but 
were not treated due to BRD morbidity.   
These observations illustrate the importance of the incidence of sub-clinical 
illness in beef cattle feeding systems and reinforce the lack of accurate detection 
methods currently in place.  Considering the visual signs of morbidity alone, no 
therapeutic treatments would have been administered in this trial.  This differs in 
comparison with the afore mentioned trials with lung lesion data, as at least part of the 
pulling and treating criteria involved visual signs of illness of pen riders or research 
personnel in those studies.  This element of human variation between studies also 
highlights the subjective nature of clinical evaluation and the profound need for 
development of effective methods of early and accurate BRD diagnosis. 
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 SUMMARY 
 The long-term goal leading to generation of steers for this project was 
development of a cattle population useful for genomic investigations of numerous 
economically important traits, with Nellore and Angus foundation animals and resulting 
crosses utilized.  Subsequently, the objective for this dissertation was to characterize 
phenotypes associated with production measures of feed intake, feeding frequency, 
growth performance, and morbidity aspects of these Bos indicus-Bos taurus crossbred 
steers of known genetic background following BRD vaccination and BVDV challenge 
that could eventually be used for genetic mapping and related genomic studies. 
Combining major areas of influence such as growth, immune response, and information 
of genetic backgrounds is relevant and is likely needed to better explain the 
relationships among these areas and how they collectively affect the overall well-being 
of cattle in beef production systems.  In an attempt to study some of these 
relationships, this project evaluated weight, rectal temperature, visual signs, feed 
intake, feed bunk visit frequency and weight gain in steers where the genetic 
background, vaccination protocol, and pathogen challenge were known. All cattle were 
verified to be free of BVDV persistent infection before the trial began. 
Weight was significantly influenced by day within year, year, sire, with a trend 
for a day × vaccine type interaction (P = 0.09), and the vaccine type by day approached 
significance as KV steers tended to be lighter across all days.  Since steers were 
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 stratified so that sires were represented across all vaccine types, there was no sire × 
vaccine type interaction on weight. None of these results were particularly surprising.   
 Rectal temperature was significantly influenced by day within year, year, and 
sire as was weight; however, pen within year, vaccine type and day by vaccine type 
interaction influenced rectal temperature only. Across vaccine types, the MLV steers 
were lower than KV and NON steers; this corresponded with a lower proportion of MLV 
steers being identified above the 40oC rectal temperature threshold established for 
antibiotic treatment.  Steers from the MLV group had lower rectal temperature than KV 
and NON steers at days 3 and 7 implying that this group may have been less impacted 
by the BVDV challenge. 
 In general daily feed intake and daily bunk visit frequency decreased from day 0 
through day 7 and increase gradually after that in all years, and this is interpreted as 
being the result of the BVDV challenge.  However, the patterns in both these traits 
were not the same across sire × vaccine type combinations or across day × vaccine type 
× rectal temperature status combinations.  For daily feed intake, variation from the sire 
group × vaccine type interaction was observed where steers in the NON group ranked 
lowest in 4 sire groups.  Much less variation between sires for daily feed intake was 
observed for both vaccinated groups, which can be a production advantage when 
vaccination is utilized; no consistent pattern was identified between all three vaccine 
types suggesting the potential of matching genotypes and vaccine strategies for 
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 optimum feed intake levels considerations, or that inherent variability may remain 
when all animals are vaccinated the same and exposed to the same pathogen. 
 While both daily feed intake and daily bunk visit frequency were significantly 
influenced by the same effects statistically, the relationship of these variables is subject 
to interpretation due to the fact that sire groups and vaccine type by sire group 
combinations were not similar in many cases between these two traits; an increase in 
daily bunk visit did not translate into higher daily feed intake.  Instead, some sire 
groups were exactly opposite of this, indicating changes in appetite in response to viral 
exposure and vaccine effectiveness can alter aggressiveness of appetite, ultimately 
altering feeding behavior, and that this relationship can be varied across family lines.   
 Rectal temperature status above the 40oC threshold contributed to reduced 
ADG in days 0 through 14 and again for days 28 through 42, but not for days 14 to 28 or 
overall from days 0 to 42.  The vaccine type by threshold rectal temperature status 
interaction also was an important source of variation for ADG in that non-vaccinated 
steers below the 40oC threshold were the highest for ADG at days 14 to 28 (possibly 
when they are recovering from viral infection), but the non-vaccinated steers over the 
40oC threshold were significantly lower for ADG during this period.  Visual signs of 
illness for this project were not distributed differently among other study factors, which 
was also the case for lung color scores although 67% of cattle below 40oC threshold 
exhibited some amount of visual discoloration.  This reinforces the need for enhanced 
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 BRD detection methods as opposed to visual evaluation or rectal temperature status 
alone.   
 These data display evidence of variation of measured values that would relate 
to vaccine response following virus exposure and further impacts on feeding behavior 
and intake.  Observations from this project promote further discussion of the influence 
that genetics have on BVDV (and other pathogen) infection and effectiveness of genetic 
interactions with vaccine protocols.  Considering the number of strains of BVDV and  
the varying levels of virulence that are associated among those strains, it is not 
unreasonable to speculate about the true prevalence and potential subclinical 
influences of BVDV in various production settings.  Future research could expound on 
differences in breeds, impact due to degree of heterozygosity from crossbreeding, 
differences due to the percentage of Bos indicus influence, or even maternal breed type 
and paternal breed type reciprocals.  The degree of variation within and across sire 
groups in these data suggests that identification of genomic influences has strong 
potential.  Additional measures of health status beyond rectal temperature and visual 
clinical symptoms such as immune systems cellular functions need further investigation 
as well, to help quantify the response variables associated with viral pathogen 
exposure. 
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